KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $211.2 million.

  • Nektar Therapeutics' Total Non-Current Liabilities fell 1623.27% to $211.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $211.2 million, marking a year-over-year decrease of 1623.27%. This contributed to the annual value of $235.9 million for FY2024, which is 1011.35% down from last year.
  • As of Q3 2025, Nektar Therapeutics' Total Non-Current Liabilities stood at $211.2 million, which was down 1623.27% from $226.1 million recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Total Non-Current Liabilities ranged from a high of $457.5 million in Q1 2021 and a low of $211.2 million during Q3 2025
  • For the 5-year period, Nektar Therapeutics' Total Non-Current Liabilities averaged around $322.2 million, with its median value being $292.2 million (2023).
  • In the last 5 years, Nektar Therapeutics' Total Non-Current Liabilities soared by 3586.25% in 2021 and then plummeted by 2717.14% in 2023.
  • Over the past 5 years, Nektar Therapeutics' Total Non-Current Liabilities (Quarter) stood at $410.0 million in 2021, then decreased by 17.94% to $336.4 million in 2022, then dropped by 22.0% to $262.4 million in 2023, then dropped by 10.11% to $235.9 million in 2024, then dropped by 10.44% to $211.2 million in 2025.
  • Its Total Non-Current Liabilities was $211.2 million in Q3 2025, compared to $226.1 million in Q2 2025 and $235.7 million in Q1 2025.